ArticleJournal of immunotherapy and precision oncology2024

Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting.

Prajwal Dhakal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.